Edition:
United States

Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TIAN.SI)

TIAN.SI on Stock Exchange of Singapore

0.79USD
29 Jul 2016
Change (% chg)

-- (--)
Prev Close
$0.79
Open
$0.79
Day's High
$0.80
Day's Low
$0.79
Volume
84,800
Avg. Vol
271,764
52-wk High
$1.47
52-wk Low
$0.73

Latest Key Developments (Source: Significant Developments)

Tianjin Zhongxin Pharmaceutical Group to pay 2015 div on July 15
Friday, 8 Jul 2016 01:29am EDT 

Tianjin Zhongxin Pharmaceutical Group <600329.SS> Corp Ltd: Says it will pay cash dividend of 1.5 yuan per 10 shares (before tax) to shareholders for 2015 as a record of July 14 .Says the company's shares will be traded ex-right and ex-dividend on July 15 and the dividend will be paid on July 15.  Full Article

Tianjin Zhongxin Pharmaceutical Group Corp Ltd updates on recall of a product from Hong Kong - Reuters News
Tuesday, 26 Apr 2016 06:27am EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:Tianjin zhong xin pharm group (update on recall of a product from Hong Kong).Tianjin market supervision committee has inspected the Long Shun Rong pharmaceutical factory.Says pursuant to recall 314 boxes have been recalled as at 24 April 2016.Company has procured the LSR factory to cease its production, recall the product from Hong Kong.Tianjin market supervision committee requested that the LSR factory cease production until any problems are rectified.Company has not received any notice about the commencement of investigations on the LSR factory.Will be sending its staff to Hong Kong to supervise Ming Hua Company in recall and destruction of product.Co suspended exports of all the Chinese medicine produced in the LSR factory to Hong Kong.  Full Article

Tianjin Zhongxin Pharmaceutical Group says 2015 dividend payment as 0.15 yuan per share
Tuesday, 29 Mar 2016 08:00pm EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:To pay cash dividend of 1.5 yuan per 10 shares (before tax) to the company's shareholders for 2015.  Full Article

Tianjin Zhongxin Pharmaceutical Group subsidiary receives GMP certificate
Friday, 18 Mar 2016 08:00pm EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:Says Tianjin-based pharmaceutical subsidiary received goods manufacture practice (GMP) certificate from Tianjin Market and Quality Supervision Administration.Certificate issued to imported drugs packaging (cephalosporin powder injection) and the valid period is until March 10, 2021.  Full Article

Tianjin Zhongxin Pharmaceutical Group completes private placement
Wednesday, 15 Jul 2015 08:00pm EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:Completed the issuance of 29,564,356 A shares at 28.28 yuan per share, through private placement to sixth companies.Raised 836,079,987.68 yuan in total through the private placement.  Full Article

Tianjin Zhongxin Pharmaceutical Group announces 2014 dividend payment date
Sunday, 24 May 2015 08:00pm EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:To pay cash dividend of 1.5 yuan per 10 shares (before tax) to shareholders for 2014 as a record of May 29.The company's shares will be traded ex-right and ex-dividend on June 1 and the dividend will be paid on June 1.  Full Article

Tianjin Zhongxin Pharmaceutical Group to set up joint venture
Thursday, 23 Apr 2015 08:00pm EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:Says to set up financial joint venture in Tianjin with four other Tianjin-based companies.Joint venture with registered capital of 500 mln yuan and the company to hold 15 pct stake in it.  Full Article

Tianjin Zhongxin Pharmaceutical Group announces change in accounting policy
Monday, 30 Mar 2015 08:00pm EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:Says change in accounting policy due to new accounting standards announced by Ministry of Finance of the People's Republic of China, effective July 1, 2014.  Full Article

Tianjin Zhongxin Pharmaceutical Group announces 2014 dividend payment
Monday, 30 Mar 2015 08:00pm EDT 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:To pay cash dividend of 1.5 yuan per 10 shares (before tax) to all shareholders for 2014.  Full Article

SGX grants extension of time to Tianjin Zhongxin Pharmaceutical Group Corp Ltd to announce audited full year results within 90 days
Tuesday, 10 Feb 2015 04:07am EST 

Tianjin Zhongxin Pharmaceutical Group Corp Ltd:Says it applied to the SGX for a waiver from requirement under Rule 705(1) of the Listing Manual to announce its full year results within 60 days of the financial year end and requested for an extension of time to release its audited full year results within 90 days of the financial year end.Says it has received a reply from the SGX stating that it has no objections to the company’s application for an extension of time to release its audited full year results for the financial year ended Dec. 31 within 90 days of the financial year end.  Full Article